Biological Assembly 1  

Global Symmetry: Cyclic - C3  (3D View)
Global Stoichiometry: Homo 6-mer - A6 

Biological assembly 1 assigned by authors and generated by PQS (software)

Macromolecule Content

• Total Structure Weight: 75.51 kDa 
• Atom Count: 5,216 
• Modelled Residue Count: 666 
• Deposited Residue Count: 680 
• Unique protein chains: 1

 2V16

Crystal Structure of Renin with Inhibitor 3

• PDB DOI: 10.2210/pdb2V16/pdb

• Classification: HYDROLASE
• Organism(s): Homo sapiens
• Expression System: Cricetulus griseus
• Mutation(s): No 


• Deposited: 2007-05-22 Released: 2008-07-08 
• Deposition Author(s): Rahuel, J., Rasetti, V., Maibaum, J., Rueger, H., Goschke, R., Cohen, N.C., Stutz, S., Cumin, F., Fuhrer, W., Wood, J.M., Grutter, M.G.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 2.80 Å
• R-Value Work: 0.214 
• R-Value Observed: 0.214 

Literature

Structure-Based Drug Design: The Discovery of Novel Nonpeptide Orally Active Inhibitors of Human Renin

Rahuel, J., Rasetti, V., Maibaum, J., Rueger, H., Goschke, R., Cohen, N.C., Stutz, S., Cumin, F., Fuhrer, W., Wood, J.M., Grutter, M.G.

(2000) Chem Biol 7: 493

• PubMed: 10903938 
• DOI: 10.1016/s1074-5521(00)00134-4
• Primary Citation of Related Structures:  
  2V0Z, 2V10, 2V11, 2V12, 2V13, 2V16


• PubMed Abstract: 
  

The aspartic proteinase renin plays an important physiological role in the regulation of blood pressure. It catalyses the first step in the conversion of angiotensinogen to the hormone angiotensin II. In the past, potent peptide inhibitors of renin have been developed, but none of these compounds has made it to the end of clinical trials. Our primary aim was to develop novel nonpeptide inhibitors. Based on the available structural information concerning renin-substrate interactions, we synthesized inhibitors in which the peptide portion was replaced by lipophilic moieties that interact with the large hydrophobic S1/S3-binding pocket in renin.

---

Related Citations: 

• The Crystal Structures of Recombinant Glycosylated Human Renin Alone and in Complex with a Transition State Analog Inhibitor.
  Rahuel, J., Priestle, J.P., Grutter, M.G.
  (1991) J Struct Biol 107: 227

---

Organizational Affiliation: 

Core Technology Area, Novartis Pharma AG, Metabolic and Cardiovascular Diseases, Basle, Switzerland.

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
RENIN	A [auth C], B [auth O]	340	Homo sapiens	Mutation(s): 0  Gene Names: REN EC: 3.4.23.15
UniProt & NIH Common Fund Data Resources
Find proteins for P00797 (Homo sapiens) Explore P00797  Go to UniProtKB:  P00797
PHAROS:  P00797

Small Molecules

Ligands 1 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram
C47	C, D [auth O]	METHYL (3R)-1-[(5S,6S,8R)-5-AMINO-9-BUTYLAMINO-6-HYDROXY-3,3,8-TRIMETHYL-9-OXO-NONANOYL]-3,4-DIHYDRO-2H-QUINOLINE-3-CARBOXYLATE C27 H43 N3 O5 VROPGBJWKDHPPG-WQJYWUQFSA-N

Binding Affinity Annotations
ID	Source	Binding Affinity
C47	PDBBind:  2V16	IC50: 6 (nM) from 1 assay(s)
	BindingDB:  2V16	IC50: 0.8 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 2.80 Å
• R-Value Work: 0.214 
• R-Value Observed: 0.214 
• Space Group: P 2₁ 3

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 142.9	α = 90
b = 142.9	β = 90
c = 142.9	γ = 90

Software Package:

Software Name	Purpose
TNT	refinement
MADNESS	data reduction

Structure Validation

Entry History 

Deposition Data

• Released Date: 2008-07-08 
Deposition Author(s): Rahuel, J., Rasetti, V., Maibaum, J., Rueger, H., Goschke, R., Cohen, N.C., Stutz, S., Cumin, F., Fuhrer, W., Wood, J.M., Grutter, M.G.

Revision History  

• Version 1.0: 2008-07-08
  Type: Initial release
  
• Version 1.1: 2011-05-08
  Changes: Version format compliance
• Version 1.2: 2011-07-13
  Changes: Version format compliance
• Version 1.3: 2017-06-28
  Changes: Data collection
• Version 1.4: 2017-07-12
  Changes: Refinement description
• Version 1.5: 2019-04-03
  Changes: Data collection, Source and taxonomy